The following represents the content we have available in
this category:
Multi-strain influenza vaccine passes first phase of clinical trials
Researchers from the University of Texas at Galveston are gearing up to present their findings in October at the Conference on Agents and Chemotherapy and the Infectious Disease Society of America. Their work, underwritten by a grant from the Bill and Melinda Gates Foundation, has led to a multi-strain influenza vaccine that has passed the first phase of clinical trials. |
|
The Minority Role in Clinical Trials
When it comes to creating an accurate picture of what it takes to cure diseases and develop vaccines, a few pieces of the puzzle are missing. |